GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea
· Delayed Price · Currency is KRW 33,700
+2,000 (6.31%)
Apr 3, 2025, 3:30 PM KST
GemVax&KAEL Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 62,692 | 72,209 | 75,804 | 60,371 | 65,663 | Upgrade
|
Other Revenue | -0 | - | - | -0 | -0 | Upgrade
|
| Revenue | 62,692 | 72,209 | 75,804 | 60,371 | 65,663 | Upgrade
|
Revenue Growth (YoY) | -13.18% | -4.74% | 25.56% | -8.06% | 53.91% | Upgrade
|
Cost of Revenue | 43,209 | 46,270 | 54,082 | 41,704 | 40,205 | Upgrade
|
Gross Profit | 19,482 | 25,938 | 21,722 | 18,667 | 25,458 | Upgrade
|
Selling, General & Admin | 20,781 | 16,360 | 12,587 | 13,462 | 17,775 | Upgrade
|
Research & Development | 35,064 | 15,670 | 11,634 | 7,241 | 4,506 | Upgrade
|
Other Operating Expenses | 354.7 | 375.96 | 291.92 | 308.43 | 338.05 | Upgrade
|
Operating Expenses | 57,819 | 33,807 | 25,652 | 21,117 | 25,499 | Upgrade
|
Operating Income | -38,337 | -7,868 | -3,929 | -2,450 | -40.62 | Upgrade
|
Interest Expense | -3,161 | -462.86 | -445.31 | -404.96 | -1,230 | Upgrade
|
Interest & Investment Income | 381.18 | 294.97 | 170.17 | 272.83 | 894.89 | Upgrade
|
Earnings From Equity Investments | -2,968 | -10,855 | -7,004 | 11,719 | -1,147 | Upgrade
|
Currency Exchange Gain (Loss) | -64.44 | 80.31 | 29.09 | 325.36 | -202.18 | Upgrade
|
Other Non Operating Income (Expenses) | -24,132 | -48.49 | 462.77 | 519.5 | 1,333 | Upgrade
|
EBT Excluding Unusual Items | -68,281 | -18,860 | -10,717 | 9,981 | -392.33 | Upgrade
|
Gain (Loss) on Sale of Investments | -18,022 | -2,531 | -8,538 | 2,166 | 2,396 | Upgrade
|
Gain (Loss) on Sale of Assets | 119.06 | -253.09 | -83.14 | -6.64 | -232.39 | Upgrade
|
Asset Writedown | -1,619 | -5,704 | -266.05 | -83.07 | -136.24 | Upgrade
|
Pretax Income | -87,803 | -27,348 | -19,604 | 12,058 | 1,635 | Upgrade
|
Income Tax Expense | -583.85 | -170.87 | - | - | - | Upgrade
|
Earnings From Continuing Operations | -87,219 | -27,177 | -19,604 | 12,058 | 1,635 | Upgrade
|
Net Income to Company | -87,219 | -27,177 | -19,604 | 12,058 | 1,635 | Upgrade
|
Net Income | -87,219 | -27,177 | -19,604 | 12,058 | 1,635 | Upgrade
|
Net Income to Common | -87,219 | -27,177 | -19,604 | 12,058 | 1,635 | Upgrade
|
Net Income Growth | - | - | - | 637.48% | - | Upgrade
|
Shares Outstanding (Basic) | 40 | 39 | 39 | 40 | 39 | Upgrade
|
Shares Outstanding (Diluted) | 40 | 39 | 39 | 43 | 39 | Upgrade
|
Shares Change (YoY) | 0.71% | -0.23% | -8.46% | 9.88% | 9.00% | Upgrade
|
EPS (Basic) | -2202.00 | -691.00 | -497.32 | 303.98 | 41.72 | Upgrade
|
EPS (Diluted) | -2202.00 | -691.00 | -497.32 | 280.00 | 41.72 | Upgrade
|
EPS Growth | - | - | - | 571.14% | - | Upgrade
|
Free Cash Flow | -31,858 | -4,895 | -12,045 | -10,341 | 3,580 | Upgrade
|
Free Cash Flow Per Share | -804.31 | -124.47 | -305.57 | -240.13 | 91.36 | Upgrade
|
Gross Margin | 31.08% | 35.92% | 28.66% | 30.92% | 38.77% | Upgrade
|
Operating Margin | -61.15% | -10.90% | -5.18% | -4.06% | -0.06% | Upgrade
|
Profit Margin | -139.12% | -37.64% | -25.86% | 19.97% | 2.49% | Upgrade
|
Free Cash Flow Margin | -50.82% | -6.78% | -15.89% | -17.13% | 5.45% | Upgrade
|
EBITDA | -33,999 | -3,877 | -890.45 | -135.45 | 1,678 | Upgrade
|
EBITDA Margin | -54.23% | -5.37% | -1.18% | -0.22% | 2.56% | Upgrade
|
D&A For EBITDA | 4,338 | 3,991 | 3,039 | 2,315 | 1,718 | Upgrade
|
EBIT | -38,337 | -7,868 | -3,929 | -2,450 | -40.62 | Upgrade
|
EBIT Margin | -61.15% | -10.90% | -5.18% | -4.06% | -0.06% | Upgrade
|
Advertising Expenses | 200.68 | 159.38 | 2.3 | 116.38 | 351.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.